BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26278491)

  • 1. [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells.
    Ono M; Oka S; Okudaira H; Nakanishi T; Mizokami A; Kobayashi M; Schuster DM; Goodman MM; Shirakami Y; Kawai K
    Nucl Med Biol; 2015 Nov; 42(11):887-92. PubMed ID: 26278491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters.
    Okudaira H; Oka S; Ono M; Nakanishi T; Schuster DM; Kobayashi M; Goodman MM; Tamai I; Kawai K; Shirakami Y
    Mol Imaging Biol; 2014 Dec; 16(6):756-64. PubMed ID: 24943499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer.
    Okudaira H; Shikano N; Nishii R; Miyagi T; Yoshimoto M; Kobayashi M; Ohe K; Nakanishi T; Tamai I; Namiki M; Kawai K
    J Nucl Med; 2011 May; 52(5):822-9. PubMed ID: 21536930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2.
    Okudaira H; Nakanishi T; Oka S; Kobayashi M; Tamagami H; Schuster DM; Goodman MM; Shirakami Y; Tamai I; Kawai K
    Nucl Med Biol; 2013 Jul; 40(5):670-5. PubMed ID: 23647854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
    Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
    Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells.
    Oka S; Okudaira H; Yoshida Y; Schuster DM; Goodman MM; Shirakami Y
    Nucl Med Biol; 2012 Jan; 39(1):109-19. PubMed ID: 21958853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Amino Acid/Drug Transporters for Renal Transport of [
    Ono M; Baden A; Okudaira H; Kobayashi M; Kawai K; Oka S; Yoshimura H
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.
    Ono M; Oka S; Okudaira H; Schuster DM; Goodman MM; Kawai K; Shirakami Y
    Brain Res; 2013 Oct; 1535():24-37. PubMed ID: 23994214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
    Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between
    Saarinen I; Jambor I; Kim M; Kuisma A; Kemppainen J; Merisaari H; Eskola O; Koskenniemi AR; Perez IM; Boström P; Taimen P; Minn H
    EJNMMI Res; 2019 May; 9(1):50. PubMed ID: 31152256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy.
    Malviya G; Patel R; Salji M; Martinez RS; Repiscak P; Mui E; Champion S; Mrowinska A; Johnson E; AlRasheedi M; Pimlott S; Lewis D; Leung HY
    EJNMMI Res; 2020 Nov; 10(1):143. PubMed ID: 33237350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid (anti-[18F]FACBC) accumulation in lymph node prostate cancer metastasis and lymphadenitis in rats.
    Kanagawa M; Doi Y; Oka S; Kobayashi R; Nakata N; Toyama M; Shirakami Y
    Nucl Med Biol; 2014 Aug; 41(7):545-51. PubMed ID: 24816330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters.
    Otsuki H; Kimura T; Yamaga T; Kosaka T; Suehiro JI; Sakurai H
    Prostate; 2017 Feb; 77(2):222-233. PubMed ID: 27696482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer.
    Sörensen J; Owenius R; Lax M; Johansson S
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):394-402. PubMed ID: 23208700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.
    Chattopadhyay I; Wang J; Qin M; Gao L; Holtz R; Vessella RL; Leach RW; Gelman IH
    Oncotarget; 2017 Feb; 8(6):10324-10347. PubMed ID: 28055971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study on the early evaluation of response to androgen receptor-targeted agents with
    Mollica V; Marchetti A; Fraccascia N; Nanni C; Tabacchi E; Malizia C; Argalia G; Rosellini M; Tassinari E; Paccapelo A; Fanti S; Massari F
    ESMO Open; 2024 May; 9(5):103448. PubMed ID: 38718704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer.
    Ferrari N; Granata I; Capaia M; Piccirillo M; Guarracino MR; Venè R; Brizzolara A; Petretto A; Inglese E; Morini M; Astigiano S; Amaro AA; Boccardo F; Balbi C; Barboro P
    Cell Commun Signal; 2017 Dec; 15(1):51. PubMed ID: 29216878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poorly Differentiated Neuroendocrine Tumor With 18F-Fluciclovine Uptake in a Patient With Metastatic Castrate-Resistant Prostate Cancer.
    Abiodun-Ojo OA; Akintayo AA; Harik LR; Bilen M; Halkar RK
    Clin Nucl Med; 2021 May; 46(5):e282-e285. PubMed ID: 33208627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in mice.
    Fokidis HB; Yieng Chin M; Ho VW; Adomat HH; Soma KK; Fazli L; Nip KM; Cox M; Krystal G; Zoubeidi A; Tomlinson Guns ES
    J Steroid Biochem Mol Biol; 2015 Jun; 150():35-45. PubMed ID: 25797030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.